Search Results 51-60 of 12819 for hypercoagulable
Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.
The first U.S. consensus statement on BPA for treatment of chronic thromboembolic pulmonary hypertension (CTEPH) was published in JACC: Cardiovascular ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The subject requires long-term anticoagulation therapy for reasons other than AFrelated stroke risk reduction, for example due to an underlying hypercoagulable ...
A greater tendency for blood to clot, also called a hypercoagulable state. An imbalance in the body of the minerals calcium or phosphate, or of the protein ...
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
Hypercoagulable state or other condition that increases risk of thrombosis. Absolute contraindications or allergy to iodinated contrast that cannot be ...
The subject requires long-term anticoagulation therapy for reasons other than AF-related stroke risk reduction, for example due to an underlying hypercoagulable ...
Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.